These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15687586)

  • 1. Genentech and breast cancer advocacy.
    Shak S; Bales R; Baughman SA; Curd JG; Fuchs HJ; Perry C; Teeter G; Leber L
    Breast Dis; 1998 Dec; 10(5-6):61-4. PubMed ID: 15687586
    [No Abstract]   [Full Text] [Related]  

  • 2. Experiences of breast cancer survivor-advocates and advocates in countries with limited resources: a shared journey in breast cancer advocacy.
    Errico KM; Rowden D
    Breast J; 2006; 12 Suppl 1():S111-6. PubMed ID: 16430394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The history of breast cancer advocacy.
    Braun S
    Breast J; 2003; 9 Suppl 2():S101-3. PubMed ID: 12713506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
    BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the effectiveness of advocacy training for breast cancer advocates in Australia.
    Davis C; Salo L; Redman S
    Eur J Cancer Care (Engl); 2001 Jun; 10(2):82-6. PubMed ID: 11829053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen.
    Adis International Ltd
    Drugs R D; 2003; 4(4):249-53. PubMed ID: 12848591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer advocacy: changing perceptions.
    Koon KP; Soldak T; Gralow JR
    Salud Publica Mex; 2009; 51 Suppl 2():s323-8. PubMed ID: 19967289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ever-changing face of breast advocacy.
    Wagner JA
    Breast; 2010 Aug; 19(4):280-3. PubMed ID: 20392642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advocacy groups for breast cancer patients.
    Waller M; Batt S
    CMAJ; 1995 Mar; 152(6):829-33. PubMed ID: 7697576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genentech caps cost of cancer drug for some patients.
    Pollack A
    N Y Times Web; 2006 Oct; ():C2. PubMed ID: 17061339
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast Cancer Survivor Advocacy at a University Hospital: Development of a Peer Support Program with Evaluation by Patients, Advocates, and Clinicians.
    Mirrielees JA; Breckheimer KR; White TA; Denure DA; Schroeder MM; Gaines ME; Wilke LG; Tevaarwerk AJ
    J Cancer Educ; 2017 Mar; 32(1):97-104. PubMed ID: 26477478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New targeted therapies in breast cancer.
    Kaklamani V; O'Regan RM
    Semin Oncol; 2004 Apr; 31(2 Suppl 4):20-5. PubMed ID: 15124130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specialist nurse counsellor interventions at the time of diagnosis of breast cancer: comparing 'advocacy' with a conventional approach.
    Ambler N; Rumsey N; Harcourt D; Khan F; Cawthorn S; Barker J
    J Adv Nurs; 1999 Feb; 29(2):445-53. PubMed ID: 10197945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genentech is poised for an anti-cancer breakthrough.
    Hoyle R
    Nat Biotechnol; 1998 Oct; 16(10):887. PubMed ID: 9788325
    [No Abstract]   [Full Text] [Related]  

  • 16. Global analysis of metastatic breast cancer policy gaps and advocacy efforts across the patient journey.
    Thrift-Perry M; Cabanes A; Cardoso F; Hunt KM; Cruz TA; Faircloth K
    Breast; 2018 Oct; 41():93-106. PubMed ID: 30025274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erlotinib OSI/Roche/Genentech.
    Kim TE; Murren JR
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1385-95. PubMed ID: 12498017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer advocacy in clinical care.
    Tripathy D
    Breast Dis; 1998 Dec; 10(5-6):3-14. PubMed ID: 15687580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public health advocacy in action: the case of unproven breast cancer screening in Australia.
    Johnson RS; Croager EJ; Kameron CB; Pratt IS; Vreugdenburg TD; Slevin T
    Public Health Res Pract; 2016 Sep; 26(4):. PubMed ID: 27714392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hu1124 (Genentech).
    Granlund H
    IDrugs; 2000 Oct; 3(10):1229-34. PubMed ID: 16049845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.